QIAGEN(QGEN)
Search documents
QIAGEN(QGEN) - 2023 Q4 - Annual Report
2024-03-10 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 or ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to or ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURI ...
Qiagen (QGEN) Up 1.1% Since Last Earnings Report: Can It Continue?
Zacks Investment Research· 2024-03-07 17:36
It has been about a month since the last earnings report for Qiagen (QGEN) . Shares have added about 1.1% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Qiagen due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. QIAGEN Q4 Earnings Lag, Operating Margin Expands QIA ...
QIAGEN (QGEN) Launches AI-Driven Biomedical Knowledge Base
Zacks Investment Research· 2024-03-04 14:41
QIAGEN N.V. (QGEN) recently launched QIAGEN Biomedical KB-AI, a new generative AI-driven knowledge base designed to propel drug discovery in the pharma and biotech industries. This new offering is designed for data scientists and bioinformaticians who are looking for the most comprehensive knowledge graphs to fuel data-driven drug discovery.The latest development will strongly boost the QIAGEN Digital Insights (“QDI”) bioinformatics business of the Genomics / NGS product group.News in DetailQIAGEN Biomedica ...
QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
Newsfilter· 2024-02-27 22:44
Venlo, the Netherlands, and Redwood City, California, Feb. 27, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA))) today announced the launch of QIAGEN Biomedical KB-AI, a new generative AI-driven knowledge base designed to propel drug discovery in the pharma and biotech industries. This new offering is designed for data scientists and bioinformaticians who are looking for the most comprehensive knowledge graphs to fuel data-driven drug discovery. QIAGEN Biomedical KB-AI is built on ...
QIAGEN (QGEN) Earns Notable Recognitions in Sustainability
Zacks Investment Research· 2024-02-19 15:10
QIAGEN N.V. (QGEN) recently announced two significant achievements in sustainability, recognized by My Green Lab — a non-profit organization dedicated to advancing sustainability in scientific research. The company earned the prestigious ACT (Accountability, Consistency, and Transparency) Environmental Impact Factor Label for the new QIAwave products and achieved My Green Lab Platinum certification for its Sample technologies R&D lab in Germany.These recognitions underscore QIAGEN’s commitment to sustainabi ...
QIAGEN(QGEN) - 2023 Q4 - Earnings Call Presentation
2024-02-11 09:56
Forward looking and intended use statements Q4: $503 million CER(1) vs outlook of ≥ $500 m CER 2023 adjusted diluted EPS Adj. EPS: ≥ $2.10 CER • QuantiFERON: +24% CER FY sales, annual sales milestone of >$400m Strong profitability profile supports capital deployment • Closely monitoring macro-economic and customer demand trends Q4 2023: +8% CER growth from non-COVID product groups Growth rates vs. Q4 2022. | Refer to appendix for product group growth at actual rates. | Tables may contain rounding difference ...
QIAGEN(QGEN) - 2023 Q4 - Earnings Call Transcript
2024-02-11 09:55
Qiagen N.V. (NYSE:QGEN) Q4 2023 Earnings Conference Call February 7, 2024 9:00 AM ET Company Participants John Gilardi - VP, Corporate Communications & IR Thierry Bernard - Chief Executive Officer Roland Sackers - Chief Financial Officer Conference Call Participants Derik De Bruin - Bank of America Odysseas Manesiotis - Berenberg Casey Woodring - JPMorgan Aisyah Noor - Morgan Stanley Douglas Schenkel - Wolfe Research Falko Friedrichs - Deutsche Bank Matthew Sykes - Goldman Sachs Operator Good day. I'm Melin ...
QIAGEN (QGEN) Q4 Earnings Miss, Operating Margin Expands
Zacks Investment Research· 2024-02-07 13:21
QIAGEN N.V.’s (QGEN) fourth-quarter 2023 adjusted earnings per share (EPS) were 55 cents (same at a constant exchange rate or CER), up 3.8% from the prior-year period. However, the figure missed the Zacks Consensus Estimate by 1.8%.The adjustment excludes the impact of certain non-recurring items like business integration, acquisition and restructuring-related expenses, purchased intangible amortization expenses and non-cash interest expense charges, among others.The GAAP EPS for the quarter was 42 cents, u ...
Qiagen (QGEN) Reports Q4 Earnings: What Key Metrics Have to Say
Zacks Investment Research· 2024-02-07 02:01
Qiagen (QGEN) reported $509.16 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 2.3%. EPS of $0.55 for the same period compares to $0.55 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $504.16 million, representing a surprise of +0.99%. The company delivered an EPS surprise of -1.79%, with the consensus EPS estimate being $0.56.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and h ...
QIAGEN (QGEN) Forges Alliance to Advance Microbiome Sciences
Zacks Investment Research· 2024-01-31 13:36
QIAGEN N.V. (QGEN) recently announced a collaboration with Penn State University, United States, to create a shared research and education facility for fast-developing microbiome sciences. The company will provide instruments and kits for preparing and processing microbial samples for the flagship project at Penn State’s Huck Institutes of the Life Sciences, “One Health Microbiome Center”, to support faculty and students.The latest development will significantly boost the company’s Life Sciences business ar ...